Trials / Terminated
TerminatedNCT00071253
Depakote Monotherapy, Olanzapine Monotherapy, and Combination Therapy of Depakote Plus Olanzapine in Stable Subjects During the Maintenance Phase of Bipolar Illness
A Randomized, Double-Blind Study of Depakote Monotherapy, Olanzapine Monotherapy, and Combination Therapy of Depakote Plus Olanzapine in Stable Subjects During the Maintenance Phase of Bipolar Illness
- Status
- Terminated
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 180 (planned)
- Sponsor
- Abbott · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to assess the efficacy and safety of continued combination therapy using Depakote plus olanzapine, vs. Depakote monotherapy and olanzapine monotherapy in stable subjects during the maintenance phase of bipolar illness.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Divalproex Sodium (Delayed-Release Tablets) | |
| DRUG | Divalproex Sodium (Extended-Release Tablets) | |
| DRUG | Olanzapine |
Timeline
- Start date
- 2003-07-01
- First posted
- 2003-10-20
- Last updated
- 2006-08-04
Locations
15 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00071253. Inclusion in this directory is not an endorsement.